Skip to content Skip to footer
VIEWPOINTS_Dr. Jay Backstrom_2023

Dr. Jay Backstrom shares insights from the Phase II TOPAZ trial for the treatment of SMA

Shots:  Dr. Jay Backstrom in an engaging conversation with PharmaShots, shares the highlights of the P-II Topaz trial designed to evaluate the safety and efficacy of apitegromab for the treatment of Spinal Muscle Atrophy (Type 2 & 3)   With the potential to transform care in SMA by directly addressing progressive muscle weakness, apitegromab aims to…

Read more